TP53 and cervical carcinoma: As expected, Androg treatment led to an increase in p53 protein in SiHa (Figure 5A) similar to that of CaSki (Figure 5B) in a dose-dependent manner, indicating the involvement of Androg in the p53 restoration in HPV16-positive cervical cancer cells.